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OBSERVATIONS CONCERNING FLUORESCENT TREPONEMAL
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In 1956 Deacon (1) et at. began studying fluo-
rescent technics in the venereal diseases and in
1957 reported a new treponemal test, the Fluo-
rescent Treponemal Antibody (FTA) Test (2),
for syphilis utilizing a fluorescent tagged antibody
technic. This test, as described, utilizes an in-
direct Coomhs technic and employs Treponerna
palliduni as antigen. Where the materials and
facilities are available this test is relatively simple
in comparison with the Treponema Pallidum Im-
mobilization Test (TPI). This new test was in-
eluded in the SERA Study (3) conducted by the
United States Public Health Service in 1956—57
and demonstrated a higher degree of sensitivity
and specificity than any of the treponemal tests,
including the Reiter Protein Complement Fixa-
tion Test.
We have compared the FTA Test with the
Reiter Protein Complement Fixation Test and
the VDRL Slide in various stages of untreated
syphilis. We have also undertaken quantitative
testing to determine FTA titers during various
stages of untreated syphilis and to relate such
titers, if possible, to the relative immunity of
syphilis. Finally, we have observed for changes
in titer following adequate therapy during the
early stages of the disease.
METHODs
The fluorescent test for treponemal antibodies
was performed using the method B technic of
Deacon, Falcone, and Harris (2). We attempted
quantitation of the test by a serum dilution tech-
nic. 7'repouetoe peltidum, Nichols strain (T.p.)
was used as antigen. This antigen, lyophilized,
was supplied by the Venereal Disease Branch of
the United States Public Health Service, Com-
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municable Disease Center, Chamblee, Georgia.
Fluorescein conjugates were Sylvana Chemical
Company's Horse Anti-human Globulin diluted
1:10; and Venereal Disease Research Laboratory's
Goat Anti-human Globulin diluted 1:80.
Tests were examined under the Leitz Ortholux
microscope with the Leitz fluorescence assembly
employing the Philips CS-iSO mercury vapor lamp.
Microscopic observations were made using the
darkfield condenser and 4 mm. dry objective.
TE5T PROCEDURE
Lyophilized T.p. was suspended in distilled
water, smears were prepared and examined by
regular darkfield illumination, and the suspension
adjusted to contain 2—10 organisms/high power
microscopic field.
Smears of the T.p. suspension were prepared on
3 by 1 inch microscopic slides. A diamond point
stylus was used to cut circles which would identify
smear area. Smears were made by dispensing one
drop to T.p. suspension (approximately 0.01 mm.)
from a capillary pipet and smoothing it out within
a circular area of about 10 mm. diameter. Slides
were air dried and gently fixed with heat.*
Serum was heated at 56 degrees C for 30 minutes.
Serum dilutions were made in Difeo Hemagglu-
tination Buffer, an isotonic sodium chloride solu-
tion, to pH 7.2—7.3. Doubling dilutions from 1:5
through 1:2560 were carried out where quantita-
tive testing was performed. (In a few instances,
when serum titers went beyond this point, further
dilutions were made and tests repeated.) Controls
included were Reactive, Weakly Reactive, Non-
reactive, and T.p. with conjugate.
Approximately 0.03 ml. (one drop from 1 ml.
pipet) of each serum dilution was placed on each
smear and spread in circular fashion. Slides were
put in a plastic container with a piece of moistened
filter paper in its top. The container was then
placed on a rotator in the 37 degrees C incubator
and rotated at 100 rpms for 30 minutes.
Slides were rinsed with buffered saline, then al-
lowed to stand in buffered saline (BS) for ten min-
utes, changing saline after five minutes. Smears
were gently blotted.
Two drops (approximately 0.03 ml.) of fluores-
* 1959 Manual on Serologic Tests for Syphilis
recommends flxation of antigen smears for 10
minutes in acetone.
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cein labeled conjugate (diluted according to stain-
ing titer with Hemagglutination Saline with 2%
Tween 80) were dispensed onto the smears from a
capillary pipet. Slides were again placed in plastic
container and rotated for 30 minutes in 37 degrees
C incubator.
After rotation, slides were rinsed as before and
allowedtostandin BSfor lOminutes. Slideswere
blotted dry and mounted at once, using a drop of
glycerin buffered saline (one part buffered saline
pH 7.2 and nine parts C.P. glycerin). Slides were
read immediately or stored in the refrigerator at
4 degrees C. Slides may be stored satisfactorily
for several days.
Readings were standardized at first against
control slides from the Venereal Disease Research
Laboratory, and later from our own previously
tested sera. Smears were read and reported as
described in the 1959 Manual of Serologic Tests for
Syphilis.
Reading Report
4+, Very strongly
fluorescent Reactive (R)
3+, Strongly fluo-
rescent Reactive (R)
2+, Moderately
fluorescent Reactive (R)
1+, Weakly fluo-
rescent Weakly reactive (WH)
— to Vaguely
visible Nonreactive (N)
The VDRL slide test and the Slide Quantitative
(Test B) were performed according to the pro-
cedures given in the 1959 Manual of Serologic Tests
for Syphilis, United States Department of Health,
Education, and Welfare, Public Health Service
(4). Antigens were from the Texas State Depart-
ment of Health, Bureau of Laboratories. The
Reiter Protein Complement Fixation Test was
performed by employing the one-fifth volume
Kolmer complement fixation technic, using H.P.
C.F. antigen (Cappel Laboratory, Inc.) as de-
scribed in the 1959 Monual of Serologic Tests for
Syphilis (4), United States Department of Health,
Education, and Welfare, Public Health Service.
I. Comparative Test Results
We compared the FTA Test, the VDRL Slide
Test, and the Reiter Protein Complement Fixa-
tion (HPCF) Test from various stages of un-
treated syphilis. Sera were selected from un-
treated syphilis patients within the Venereal
Disease Clinic, Houston, Texas, after careful
diagnostic evaluation. Darkflelds were positive
in two-thirds of the eases of primary and sec-
ondary syphilis.
RESULT5
The results are shown in Table I. It will he
noted that in primary syphilis 19.23% of the
specimens shown gave a reactive FTA in the face
of a nonreactive VDRL and RPCF. No case of
primary syphilis had a reactive VDRL or RPCF
with a negative FTA. Tn 65.39% of the cases of
primary syphilis there was complete correlation
between all tests, taking both (+) and (—) cor-
relation into consideration. In secondary syphilis
14 of the 15 patients were positive to all 3 tests;
one patient had a reactive FTA and VDRL but
a nonreactive RPCF. Nineteen of 20 eases of early
latent syphilis had all 3 tests reactive; the other
Test Result
FTA VDRL RPCF
+ + +
+ +
+ - +
+
- + +
- +
- - +
Total.
Late latent
Number Per cent
10 71.43
2 9.28
0 0
0 0
2 9.28
0 0
0 0
0 0
Number Per rent
56 74.67
6 8.00
2 2.67
5 6.67
2 2.66
0 0
0 0
4 5.33
75 100.00
TABLE I
Comparison of test results by stages of syphilis
Stages uf Syphilis
Primary
Number Per rent
Sernndary
Number Per rent
Early latent
Number Per rent
All Grnups
13
2
2
5
0
0
0
4
50.0
7.69
7.69
19.23
0
0
0
15.39
14
1
0
0
0
0
0
0
93.33
6.67
0
0
0
0
0
0
19
1
0
0
0
0
0
0
95.00
5.00
0
0
0
0
0
0
26 100.00 15 100.00 20 100.00 14 100.00
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TABLE II
Relative sensitivity of tests by stages of syphilis
Stage of Syphilis
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serum was FTA and VDRL reactive but nonre-
active on RPCF. In late latent syphilis all tests
were reactive in 10 of 14 patients; with nonre-
active RPCF's occurring in two cases and non-
reactive FTA's in 2 additional cases. Of all syphi-
lis patients studied nearly 75% were reactive to
all 3 tests and 6.7% were reactive only to the FTA
test.
Table II shows the percent of reactivity by
stages of the disease. In primary syphilis the FTA
test was reactive in 84.61 % of the cases while the
VDRL and RPCF Tests were reactive in only
57.69%. In secondary syphilis both the YDRL and
FTA tests were reactive in 100% of the eases. One
patient with secondary syphilis had a nonreac-
tive RPCF. In early latent syphilis the FTA and
VDRL tests were reactive in all of the patients
while the RPCF was nonreactive in one patient.
Ta late latent syphilis the FTA and RPCF tests
were reactive in only 85.71% while the VDRL
shows 100% agreement. * For all stages of syphilis
the percent of reactive specimens were 92, 85,
and 80 percent for the FTA, YDRL, and RPCF,
respectively.
In 60 normal specimens examined we obtained
nonreactive results on all 3 tests. We have also
had an opportunity to obtain follow-up serum
specimens from eases of syphilis following treat-
ment, as well as specimens from patients with
other diseases. The results of all specimens ex-
amined are shown in Table III. There was com-
plete agreement (reactive and nonreactive re-
sults) among all tests in 79.39% of the eases.
* J should be pointed out that the VDRL was
the test used clinically for the diagnosis, which
accounts for the complete correlation between the
VDRL and latent disease.
TABLE III
Comparison of test results on ott specimens
examined
Test Result All Groups
PTA YnaL RPCF Number Per cent
+ + + 94 42.15
+ + — 13 5.83
+ — + 10 4.48
+ — — 16 7.17
—
—
+
+
+
—
3
1
1.34
.45
— — + 3 1.34
— — — 83 37.24
Total 223
The RPCF alone was nonreactive in 5.83%, the
VDRL was nonreactive alone in 4.48%, and the
FTA was nonreactive alone in 1.34%. The FTA
was reactive alone in 7.17% of the eases, a high
percentage of this total being derived from pri-
mary eases of syphilis. The VDRL was reactive
alone in only 0.45% of the cases, since diagnoses
of latent syphilis were primarily based upon this
test. The RPCF was reactive alone in 1.34% of
the cases.
DISCUSSION
The SERA Study (3) conducted by the United
States Public Health Service in 1956—57 has
shown the appearance of the antibody responsible
of the immobilization of Treponema in the TPI
test to appear later in the course of syphilis than
reagin, as measured by the Standard Serologic
Test for Syphilis. Deacon (5), on the basis of
Test
Number Per cent Number
Primary Seronclary Early latent Late latent
FTA
V1)RL
RPCF
Number of speci-
mens examined.
Per cent Number Per cent
84.61
57.69
57.69
Number
22
15
15
26
All Groups
Number Per centPer cent
100.0
100.0
93.33
15
15
14
15
100.0
100.0
95.0
20
20
19
20
85.71
100.0
85.71
12
14
12
14
92.0
85.06
80.0
69
64
60
75
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FIG. 1
absorption studies, has expressed the opinion
that the antibody reacting in the FTA test and
the antibody causing immobilization of Trepo-
nema pallidum in the TPI test are probably
identical. The early appearance of the reactive
FTA in primary syphilis suggests the measure-
ment of a different antibody, or if the FTA and
TPI tests measure the same antibody, one must
assume the FTA to be a far more sensitive test
than the TPI. Such an hypothesis would not ex-
plain the two nonreactive FTA tests which oc-
cnrred in late latents, a stage of the disease where
the TPI is nearly always reactive. The two pa-
tients in question both had low titers on the
VDRL quantitative test and may well represent
either treated cases, despite our inability to
elicit such a history, or biological false positives.
Both, however, were reactive to the RPCF.
The RPCF gave the poorest over-all result
of the tests compared. In two patients, one with
secondary syphilis and the other with early latent
syphilis, this test was nonreactive. The VDRL
slide gave good reports in latent syphilis auto-
matically, since it was our primary diagnostic
procedure. In early infectious syphilis it per-
formed as might be anticipated, being reactive
in about two-thirds of the primaries and reactive
in all cases of secondary syphilis.
II. Quantitative Testing
Quantitative testing was undertaken to de-
termine if any correlation existed between the
amount of fluorescent treponemal antibody pres-
ent and relative immunity to syphilis. Magnuson
et at. (6) were able to demonstrate, from the work
at Sing Sing, a direct correlation between im-
munity and the duration of untreated syphilis in
humans. It seemed reasonable that if the anti-
body measured with the fluorescent technic were
related to this immune status that it should be
detectable in larger amounts in untreated late
latent syphilis than during the primary or sec-
ondary stages of the disease.
RESULTS
A comparison of the FTA quantitative test
results with the VDRL quantitative reveals the
FTA to be a far more sensitive test than the
VDRL in terms of serum dilution titers. A titer
as high as 1:5120 was found in one early latent
serum, and the mean FTA titer of 268 was ten
times the mean VDRL titer of 27. In Figure 1 we
have presented graphically the difference between
the VDRL and FTA quantitative results by
stages of the disease. We have employed median
values rather than the mean since this minimizes
the distortion produced by a few high or low
titered specimens. It will be noted from Figure 1
that the highest median titers were observed
during the secondary stage of syphilis for both
the VDRL and FTA tests. This, of course, was
anticipated for the VDRL.
DISCUSSION
In view of the decline of the FTA titer during
the latent phases it would appear that the pro-
duction of FTA antibody follows a pattern simi-
lar to reagin. Such a pattern may indicate that
the FTA antibody is not directly related to the
immunity which develops during the late stages
of untreated syphilis.
Reproducibility of the qualitative FTA test,
that is the 1:5 dilution, on 59 specimens was
100%. From the diagnostic standpoint we see no
advantage of a quantitative over a qualitative
test. Our quantitative studies were undertaken
for investigative purposes only. On these 59 speci-
mens selected at random from frozen aliquots of
the original serum we were able to reproduce our
original results on only 49.1 % of the serums. Re-
productions of our original titers within one dilu-
tion factor was only 76.2%. While this is poor
and does not compare with the YDRL reproduci-
bility we feel that it is satisfactory for the de-
termination of general trends occurring in
syplulis.
The FTA quantitative technic employed is
still a rough technic. The amount of antigen em-
ployed has to be controlled microscopically by
suspending Treponema pattidum in solution and
determining the concentration per high power
COMPARISON OF MEDIAN TITERS FOR FTA AND VDRL TESTS
BY STAGES OF SYPHILIS
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TABLE IV
F7'A and VDJIL follow-up on treated primary syphilis
Serum Dilution Reactive
FTA and VDRL follow-up on treated secondary syphilis
R = Reactive on qualitative test only.
WR = Weakly reactive on qualitative test.
NR = Nonreactive.
Serum Dilution Reactive
VDRL
Months follow-up
3 4
R
24
WR
8 WR
32
14 2
field. The distinction between reactive and
weakly reactive was so fine that exact reproduc-
tion was difficult. To determine the end-point the
technician must decide the dilution where faint
fluorescence ends and bright fluorescence begins.
111. Response to Therapy
Using the quantitative FTA test, we have ob-
served for changes in titer following therapy
during the early stages of syphilis. Primary, sec-
ondary, and early latent syphilis patients with a
minimum of 3 months follow-up were selected
for study.
RESULTS
Original and follow-up specimens for primary
syphilis are shown in Table IV for both FTA and
VDRL tests. Eight of the 11 patients followed
show a drop in titer and 5 were nonreactive on the
last report. One titer remained unchanged and 2
had relatively minor increases in titer.
Reports from secondary syphilis patients are
FTA
Months follow-up
2 3
160 WR
WRR WR
40
Patient
1
2
3
4
5
6
7
8
9
10
11
VDRL
Months follow-up
4 5
10 10R R
NR WR
320
20
WR
640
80
WR
WR
R
320
20
40
80
R
10
20
80
WR
6
40
R
NR
NR
NR
1 2
16 4
WR
NR NR
WR
WR
40
NR
Nil
R
64
R
NR
8
NR
NR
NR
NR
16
R
256
Nil
Nil
R
R
WR
NR
Nil
NR
NR
WR
Nil
Nil
NR
NR
il
NR
NR
Nil
Nil
Nil
WR
Nil
10
80
2
R
NR
Nil
Nil
Nil
Nil
4
Nil
WR
4
Nil
Nil
Nil
R
TABLE V
R = Reactive on qualitative test only.
WR = Weakly reactive on qualitative test.
Nil = Nonreactive.
Patient
1
2
3
4
5
6
7
FTA
Months follow-up
320
40
640
80
640
20
20
6
40
1 2
160
20
1 24 5
160
80
80
20
Nil
40
R
64
64
32
64
128
64
32
6
R
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TABLE VI
FTA and VDRL follow-up on treated early latent syphilis
Serum Dilutions Reactive
shown in Table V. Four of the 7 had reductions
in titer, one has remained unchanged, and 2 have
shown elevations. None of the secondaries have
become nonreactive.
Results on early latent patients are shown in
Table VI. Ten of the 15 early latents have had
reductions in titer; 2 have become nonreactive,
both of whom had low original titers. In 2 cases
the titer has remained unchanged, and in 3 cases
titers have gone up.
DISCUSSION
It will be observed that we encountered fluctua-
tions in serum titers during this period of
follow-up. It is our opinion that these fluctuations
were due to the inadequacies of the technic em-
ployed and not due to wide antibody fluctua-
tions. This viewpoint is suggested by the fact
that the number of reports well outside the antici-
pated trend correlated relatively well with our
above quoted reproducibility figures.
In all stages of syphilis 67% of the cases show
a drop in titer, and 79% either dropped or re-
mained the same. From these results we conclude
that the amount of antibody detected using the
FTA test diminished following therapy in early
syphilis, but that this drop is not nearly as rapid
as that occurring with the VDRL.
SUMMARY
1. A comparison of the FTA test with the
VDRL slide test and RPCF test shows that the
FTA becomes reactive earlier in the course of
syphilis than either of the other two tests.
2. This study suggests that the FTA either
detects a different antibody from the TPI test,
or that it is a more sensitive test than the TPI.
3. Quantitative determinations of FTA anti-
body were performed using a serum dilution
technic. It was found that FTA antibody was de-
tectable in higher titers than was reagin (as
measured by the VDRL).
4. The FTA followed much the same pattern
as reagin, with the highest titers being found in
secondary syphilis. This would suggest that the
antibody measured is not responsible for the
relative immunity observed in late syphilis.
5. The FTA showed a reduction in titer fol-
lowing treatment but was detectable over a more
prolonged period than the VDRL.
FTA
Months follow-up
3 4
160
20
VDRL
Months follow-up
7
R
Patient
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
5 6
40
10
10
20
0
80
20
640
20
40
40 10
5120
40
20
1280
640
40
40
10
10
1 2
4
8
WR
160
80
20
NR
R
10
R
640
160
40
80
10
NR
4 5 6
16 4
R
WR
NR
8
16
4
4
R
8
64
R
64
8
64
8
R
64
32
2
8
WR
WR
R
2
R
8
4
4
4
WR
NR
R = Reactive on qualitative test only.
WR = Weakly reactive on qualitative test.
NR = Nonreactive.
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